博晖创新：冻干人用狂犬病疫苗临床试验获批

Core Viewpoint - The company BoHui Innovation (300318) announced that its subsidiary BoHui Biopharmaceutical Co., Ltd. has received approval from the National Medical Products Administration to conduct clinical trials for a freeze-dried rabies vaccine using human diploid cells [1] Group 1 - BoHui Biopharmaceutical Co., Ltd. is collaborating with Beijing Baihui Biotechnology Co., Ltd. for the rabies vaccine project [1] - The approval includes a formal notification for the initiation of clinical trials [1]